The site where students compete, learn, and make money Thursday, October 9, 2008
DJIA: -267.69 NASD: -35.94 10-YR: 0.1
 
 
 
 
     
 
     

Contests

Leaderboard - Portfolio

Current Balance: $13409.80
symbolnumber of sharesbuying pricecurrent pricenet change
PS WATER RESOURCE (PHO)100019.4714.24 $-5,227.00 (-26.85%)info - chart
NATL OILWELL VARC (NOV)10057.2731.39 $-2,588.00 (-45.19%)info - chart
GOL LINHAS AEREAS (GOL)100020.704.24 $-16,460.00 (-79.52%)info - chart
GILEAD SCIENCES (GILD)20047.850.00 $-9,570.00 (-100%)info - chart
POWERSHARES DB AG (DBA)25034.9427.12 $-1,955.00 (-22.38%)info - chart
JOHNSON AND JOHNS (JNJ)25062.6560.32 $-582.50 (-3.72%)info - chart
Portfolio Value:$56891.8 (-43.11%)

Related News

Comments


GOL Linhas Aereas Inteligentes SA (NYSE:GOL) - Significant decline ...
Research Oracle, UK - Oct 7, 2008
GOL Linhas Aereas Inteligentes SA?s (GOL) stock has declined significantly since our last update report in response to the ongoing turmoil in global ...
GOL Announces Traffic Statistics for September 2008 Earthtimes (press release)
all 10 news articles
 

Boston Scientific revises estimates
Bizjournals.com, NC - 3 hours ago
... $334 million based on the ruling last week that it pay Johnson & Johnson (NYSE: JNJ) $703 million for infringing on patents regarding coronary stents. ...
Boston Scientific Announces Third Quarter Adjustments Trading Markets (press release)
all 35 news articles
 

Market turmoil forces Boston Scientific Corp. co-founders to sell ...
Bizjournals.com, NC - 3 hours ago
That charge stems from a court ruling that it must pay Johnson & Johnson (NYSE: JNJ) $703 million for infringing on patents regarding coronary stents.
 

Investing Lessons From Three Mile Island
Motley Fool - 3 hours ago
Think of Johnson & Johnson (NYSE: JNJ), for example, and its Tylenol-tampering scare in 1982. The company moved swiftly to remove possibly tainted products ...
 

Gilead Sciences Inc (NASDAQ:GILD) to Present at UBS Global Life ...
TransWorldNews (press release), GA - Sep 17, 2008
Gilead Sciences, Inc (NASDAQ:GILD) will speak at the UBS Global Life Sciences Conference on Tuesday, September 23 at 9:30 am ET. ...
 

Lilly Gets Off Easy
Motley Fool - 23 hours ago
Even Johnson & Johnson's (NYSE: JNJ) Risperdal couldn't catch Zyprexa, although if you add in its long-lasting Risperdal Consta it comes close at almost ...
 

5 More Top Growth Stocks
Motley Fool - 22 hours ago
It's an important market, especially for Crosseal distributor Johnson & Johnson (NYSE: JNJ), which was recently rumored to be among those ready to acquire ...
 

National Oilwell Varco, Inc. (NYSE:NOV) - Significant decline in ...
Research Oracle, UK - Sep 10, 2008
National Oilwell Varco, Inc.?s (NOV) NYSE common stock has declined significantly since our last update report reflecting a fall in global crude oil prices. ...
 

Boston Scientific (BSX) Sell-Off Appears Unwarranted -Piper Jaffray
StreetInsider.com (subscription), MI - 3 hours ago
Piper believes that: Boston Scientific has the ability to pay the $700 million in damages from Johnson & Johnson's (NYSE: JNJ) patent infringement case. ...
 

The Flight to Safety Could Burn You
Motley Fool - 23 hours ago
... Johnson & Johnson (NYSE: JNJ) and Procter & Gamble (NYSE: PG) -- some of it on this website. After all, the story goes, even when times are tough, ...
 

DBA

Submitted by lucas20 on February 1,2008 02:20:11 PM

Still up, nice.